Redx Pharma

Anti-viralsOncologyUK

Redx Pharma

Redx Pharma is a UK-based technology development resource for the global pharmaceutical market. The company is focused on the development of a wide range of early stage, proprietary small molecule therapeutics to address unmet medical needs.

Redx Pharma is a UK-based technology development resource for the global pharmaceutical market.  The company is focused on the development of a wide range of early stage, proprietary small molecule therapeutics to address unmet medical needs.

Headquartered in Liverpool, Redx Pharma's priorities are currently in oncology and anti-infectives, both antibacterials and antivirals, with programmes being progressed through preclinical development.

The company’s proprietary Redox Switch approach has allowed the company to secure a broad portfolio of intellectual property covering around 200 families of compounds – each based upon an existing commercial or late clinical-stage drug.

Redx Pharma was the only UK biotech business supported by the Government's Regional Growth Fund, in a major round of funding at the end of 2011. In 2012 Redx Pharma was awarded £5.9 million to support a project to create an Oncology Research Centre and creating 250 bioscience jobs in Liverpool.


Latest Articles

Parexel

Parexel

Back to top